ATryn is a recombinant antithrombin indicated for the prevention of peri-operative and peri-partum thromboembolic events in hereditary antithrombin deficient patients.

Berinert, human plasma-derived, purified, pasteurized concentrate of the protein C1 esterase inhibitor, is specifically indicated for the treatment of acute facial or abdominal attacks of hereditary angioedema (HAE) in adult and adolescent patients.

Thrombate III, a preparation of antithrombin concentrate purified from human plasma, is indicated for the treatment of patients with hereditary antithrombin deficiency in connection with surgical or obstetrical procedures or when they suffer from thromboembolism.